Oregon Public Employees Retirement Fund Has $167,000 Stake in Cigna Corp (CI)

Oregon Public Employees Retirement Fund increased its position in Cigna Corp (NYSE:CI) by 42,687.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,752,725 shares of the health services provider’s stock after acquiring an additional 31,678,514 shares during the quarter. Oregon Public Employees Retirement Fund owned about 0.13% of Cigna worth $167,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Mascoma Wealth Management LLC lifted its position in Cigna by 8.1% during the fourth quarter. Mascoma Wealth Management LLC now owns 709 shares of the health services provider’s stock valued at $135,000 after purchasing an additional 53 shares during the last quarter. Howe & Rusling Inc. lifted its position in Cigna by 1.3% during the fourth quarter. Howe & Rusling Inc. now owns 4,585 shares of the health services provider’s stock valued at $871,000 after purchasing an additional 61 shares during the last quarter. First Command Bank lifted its position in Cigna by 11.8% during the fourth quarter. First Command Bank now owns 636 shares of the health services provider’s stock valued at $121,000 after purchasing an additional 67 shares during the last quarter. First Command Financial Services Inc. lifted its position in Cigna by 11.8% during the fourth quarter. First Command Financial Services Inc. now owns 636 shares of the health services provider’s stock valued at $121,000 after purchasing an additional 67 shares during the last quarter. Finally, First Financial Corp IN lifted its position in Cigna by 10.1% during the fourth quarter. First Financial Corp IN now owns 786 shares of the health services provider’s stock valued at $150,000 after purchasing an additional 72 shares during the last quarter. Institutional investors own 93.44% of the company’s stock.

Shares of CI opened at $197.87 on Monday. The company has a market capitalization of $48.19 billion, a PE ratio of 13.91, a price-to-earnings-growth ratio of 0.93 and a beta of 0.72. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.98. Cigna Corp has a fifty-two week low of $163.02 and a fifty-two week high of $226.60.

Cigna (NYSE:CI) last announced its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.53 by ($0.07). The business had revenue of $13.75 billion during the quarter, compared to the consensus estimate of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company’s revenue was up 29.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.94 earnings per share. Equities research analysts expect that Cigna Corp will post 16.4 earnings per share for the current year.

In related news, insider Michael W. Triplett sold 9,148 shares of Cigna stock in a transaction on Monday, February 11th. The shares were sold at an average price of $181.01, for a total value of $1,655,879.48. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director William D. Zollars sold 201 shares of Cigna stock in a transaction on Friday, December 14th. The stock was sold at an average price of $210.84, for a total transaction of $42,378.84. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 10,349 shares of company stock worth $1,882,688. 1.10% of the stock is owned by insiders.

Several equities research analysts have issued reports on the stock. Zacks Investment Research reiterated a “strong-buy” rating and set a $246.00 target price on shares of Cigna in a research report on Monday, November 12th. Leerink Swann lifted their target price on shares of Cigna from $250.00 to $260.00 and gave the company an “outperform” rating in a research report on Monday, November 19th. BMO Capital Markets boosted their price objective on shares of Cigna from $220.00 to $230.00 and gave the stock a “hold” rating in a report on Friday, November 2nd. Barclays boosted their price objective on shares of Cigna from $228.00 to $235.00 and gave the stock an “overweight” rating in a report on Friday, November 2nd. Finally, Citigroup boosted their price objective on shares of Cigna from $243.00 to $249.00 and gave the stock a “buy” rating in a report on Friday, November 2nd. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $229.09.

WARNING: This story was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2019/02/18/oregon-public-employees-retirement-fund-has-167000-stake-in-cigna-corp-ci.html.

About Cigna

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: How Do Mutual Funds Work?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.